Vault-13

Venrock Adviser, LLC

NEW YORK, NY · CIK 1615982 · 13F filing filed 2021-05-14

SEC-registered investment adviser since 2014 · limited liability company

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
New York, NY (main office)United States United Statesabout 11
Palo Alto, CAUnited States United States

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$921.8m reported value +35.5% vs Q4 2020
28positions
73.1%in top 10
7 new 7 added 5 reduced 4 sold out vs Q4 2020

Holdings, Q1 2021

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 INSTIL BIO INC COM COM 6,865,076 $172.2m18.68% 18.68% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 6.9m
2 CONSTELLATION PHARMCETICLS I COM CNST CNST 4,016,873 $94.0m10.19% 10.19% UnchangedShares held: Q2 2020 4.0m, Q3 2020 4.0m, Q4 2020 4.0m, Q1 2021 4.0m
3 ACLARIS THERAPEUTICS INC COM ACRS ACRS 3,720,582 $93.8m10.17% 10.17% AddedShares held: Q2 2020 0, Q3 2020 0, Q4 2020 2.0m, Q1 2021 3.7m +1.8m +1,765,650 90.3%
4 OLEMA PHARMACEUTICALS INC COM OLMA OLMA 1,536,193 $51.0m5.53% 5.53% UnchangedShares held: Q2 2020 0, Q3 2020 0, Q4 2020 1.5m, Q1 2021 1.5m
5 ALTIMMUNE INC COM NEW ALT ALT 3,500,000 $49.5m5.37% 5.37% ReducedShares held: Q2 2020 4.5m, Q3 2020 4.5m, Q4 2020 4.5m, Q1 2021 3.5m -1.0m -1,000,000 -22.2%
6 CULLINAN THERAPEUTICS INC COM CGEM CGEM 1,176,145 $49.0m5.32% 5.32% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 1.2m
7 KINNATE BIOPHARMA INC COM KNTE KNTE 1,473,014 $45.9m4.98% 4.98% UnchangedShares held: Q2 2020 0, Q3 2020 0, Q4 2020 1.5m, Q1 2021 1.5m
8 TRILLIUM THERAPEUTICS INC COM NEW TR TR 4,040,000 $43.4m4.71% 4.71% UnchangedShares held: Q2 2020 6.8m, Q3 2020 7.2m, Q4 2020 4.0m, Q1 2021 4.0m
9 MARINUS PHARMACEUTICALS INC COM NEW MRNS MRNS 2,641,809 $40.9m4.44% 4.44% AddedShares held: Q2 2020 0, Q3 2020 0, Q4 2020 2.6m, Q1 2021 2.6m +52.9k +52,868 2.0%
10 VISTAGEN THERAPEUTICS INC COM NEW VTGN VTGN 16,302,596 $34.7m3.77% 3.77% AddedShares held: Q2 2020 0, Q3 2020 0, Q4 2020 9.4m, Q1 2021 16.3m +6.9m +6,942,596 74.2%
11 ATHIRA PHARMA INC COM COM 1,691,623 $31.1m3.38% 3.38% UnchangedShares held: Q2 2020 0, Q3 2020 1.5m, Q4 2020 1.7m, Q1 2021 1.7m
12 RELMADA THERAPEUTICS INC COM RLMD RLMD 853,206 $30.0m3.26% 3.26% AddedShares held: Q2 2020 668.4k, Q3 2020 668.4k, Q4 2020 668.4k, Q1 2021 853.2k +184.8k +184,766 27.6%
13 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 1,240,610 $25.6m2.77% 2.77% AddedShares held: Q2 2020 0, Q3 2020 800.0k, Q4 2020 800.0k, Q1 2021 1.2m +440.6k +440,610 55.1%
14 PHARVARIS N V COM PHVS PHVS 902,882 $25.3m2.75% 2.75% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 902.9k
15 KEROS THERAPEUTICS INC COM KROS KROS 372,306 $22.9m2.49% 2.49% ReducedShares held: Q2 2020 672.3k, Q3 2020 672.3k, Q4 2020 672.3k, Q1 2021 372.3k -300.0k -300,000 -44.6%
16 ESSA PHARMA INC COM NEW EPI EPI 625,754 $18.2m1.97% 1.97% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 625.8k
17 KURA ONCOLOGY INC COM KURA KURA 575,000 $16.3m1.76% 1.76% UnchangedShares held: Q2 2020 575.0k, Q3 2020 575.0k, Q4 2020 575.0k, Q1 2021 575.0k
18 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 591,782 $13.2m1.44% 1.44% ReducedShares held: Q2 2020 625.7k, Q3 2020 625.7k, Q4 2020 1.1m, Q1 2021 591.8k -523.5k -523,473 -46.9%
19 ADICET BIO INC COM COM 1,000,000 $13.1m1.42% 1.42% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 1.0m
20 APTOSE BIOSCIENCES INC COM NEW COM NEW 1,605,400 $9.6m1.04% 1.04% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 1.6m
21 COGENT BIOSCIENCES INC COM COGT COGT 1,088,817 $9.6m1.04% 1.04% UnchangedShares held: Q2 2020 0, Q3 2020 0, Q4 2020 1.1m, Q1 2021 1.1m
22 ALIGOS THERAPEUTICS INC COM COM 408,377 $9.3m1.01% 1.01% AddedShares held: Q2 2020 0, Q3 2020 0, Q4 2020 404.9k, Q1 2021 408.4k +3.5k +3,471 0.9%
23 EYEPOINT PHARMACEUTICALS INC COM NEW EYPT EYPT 700,000 $7.1m0.77% 0.77% NewShares held: Q2 2020 0, Q3 2020 0, Q4 2020 0, Q1 2021 700.0k
24 BCTG ACQUISITION CORP COM COM 500,000 $5.6m0.60% 0.60% UnchangedShares held: Q2 2020 0, Q3 2020 500.0k, Q4 2020 500.0k, Q1 2021 500.0k
25 METACRINE INC COM COM 680,000 $4.2m0.46% 0.46% ReducedShares held: Q2 2020 0, Q3 2020 1.1m, Q4 2020 693.7k, Q1 2021 680.0k -13.7k -13,673 -2.0%
26 ARS PHARMACEUTICALS INC COM SPRY SPRY 85,000 $3.7m0.40% 0.40% ReducedShares held: Q2 2020 0, Q3 2020 0, Q4 2020 150.0k, Q1 2021 85.0k -65.0k -65,000 -43.3%
27 TAYSHA GENE THERAPIES INC COM SHS TSHA TSHA 120,649 $2.4m0.27% 0.27% AddedShares held: Q2 2020 0, Q3 2020 108.0k, Q4 2020 108.0k, Q1 2021 120.6k +12.7k +12,667 11.7%
28 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 19,495 $326.0k0.04% 0.04% UnchangedShares held: Q2 2020 0, Q3 2020 0, Q4 2020 19.5k, Q1 2021 19.5k

Sold out since Q4 2020

SecurityTickerShares held beforeValue then
SURFACE ONCOLOGY INC SURF SURF 1,442,895 $13.3m1.4m shares
GALERA THERAPEUTICS INC 917,860 $9.4m917.9k shares
FIVE PRIME THERAPEUTICS INC FPRX FPRX 245,122 $4.2m245.1k shares
BIOATLA INC BCAB BCAB 100,000 $3.4m100.0k shares